|
Market Closed -
OTC Markets
11:14:46 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 49.15 USD | +3.26% |
|
-.--% | +35.18% |
| 08-21 | Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc. | CI |
| 08-21 | Ipsen Wraps Up Purchase of US-based Kartos Therapeutics | MT |
| Market Cap | 13.5B 15.69B 12.71B 11.61B 21.71B 1,482B 21.77B 150B 58.26B 760B 58.93B 57.64B 2,449B | P/E 2026 * |
13.7x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 12.27B 14.25B 11.54B 10.54B 19.72B 1,346B 19.77B 136B 52.92B 690B 53.53B 52.36B 2,224B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 2.42x |
| Free-Float |
40.65% | Yield 2026 * |
0.93% | Yield 2027 * | 0.93% |
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IPSEY | Delayed | |
Deutsche Boerse AG
| I7G0 | Delayed | |
|
Börse Stuttgart
| I7G0 | Delayed |
Last Transcript : Ipsen S.A.
| 1 day | +3.26% | ||
| 1 month | +5.70% | ||
| 3 months | +9.13% | ||
| 6 months | +7.10% | ||
| Current year | +35.18% |
| 1 month | 45.03 |  | 49.15 |
| Current year | 34.34 | | 51.1 |
| 1 year | 32.02 | | 51.1 |
| 3 years | 25.11 | | 51.1 |
| 5 years | 21.17 | | 51.1 |
| 10 years | 9.1 | | 51.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Loew
CEO | Chief Executive Officer | 59 | 2020-06-30 |
| Chief Executive Officer | 57 | 2019-12-31 | |
Pierrick Lefranc
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Antoine Flochel
BRD | Director/Board Member | 61 | 2005-08-29 |
| Chairman | 68 | 2010-11-21 | |
Carol Xueref
BRD | Director/Board Member | 69 | 2012-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.26% | -.--% | - | - | 15.69B | |
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | |
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | |
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | |
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | |
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | |
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | |
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | |
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | |
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | |
| Average | -0.51% | +1.09% | +28.65% | +52.33% | 408.71B | |
| Weighted average by Cap. | -0.94% | +0.55% | +37.63% | +67.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.54B 5.28B 4.27B 3.9B 7.31B 499B 7.32B 50.51B 19.6B 256B 19.83B 19.39B 824B | 4.64B 5.39B 4.36B 3.99B 7.46B 509B 7.48B 51.55B 20.01B 261B 20.24B 19.79B 841B |
| Net income | 1.01B 1.17B 951M 869M 1.63B 111B 1.63B 11.24B 4.36B 56.9B 4.41B 4.31B 183B | 985M 1.15B 927M 847M 1.58B 108B 1.59B 10.96B 4.25B 55.47B 4.3B 4.21B 179B |
| Net Debt | -1.24B -1.44B -1.16B -1.06B -1.99B -136B -2B -13.76B -5.34B -69.69B -5.4B -5.28B -225B | -2.3B -2.67B -2.16B -1.98B -3.7B -252B -3.71B -25.56B -9.92B -129B -10.03B -9.82B -417B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPN Stock
- IPSEY Stock
Select your edition
All financial news and data tailored to specific country editions
